Trial Details
COMPLETEDBasic Information
| Clinical ID | c3220 |
|---|---|
| Identifier | NCT02371499 |
| Trial Title | Effect of Lactobacillus Casei DG (Enterolactis Plus®) in Patient With Irritable Bowel Syndrome: a Pilot Study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome |
| Interventions | DIETARY_SUPPLEMENT: Lactobacillus casei DG|DIETARY_SUPPLEMENT: Placebo |
Participant Information
| Sponsor | SOFAR S.p.A. |
|---|---|
| City | San Donato |
| Country/Region | Italy |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | NA |
Time Information
| Start Date | 2014-12 |
|---|---|
| Primary Completion Date | 2015-11 |
| Completion Date | 2015-11 |